Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma

Igor N. Ivashko, Jill M. Kolesar

Research output: Contribution to journalReview articlepeer-review

72 Scopus citations

Fingerprint

Dive into the research topics of 'Pembrolizumab and nivolumab: PD-1 inhibitors for advanced melanoma'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science